According to Research Professional, UK government has extended a financial “safety net” for successful UK applicants to Horizon Europe (HEU). This follows last November’s guarantee for the limited number of “first wave” of funding calls from the European Union’s €95.5 billion (£80.5bn) R&D programme.
On 15 March, 2022 science minister George Freeman extended the guarantee to awards that are expected to be signed by the end of December 2022, while efforts continued to associate to the programme. The announcement comes after yesterday’s news that the business department has allocated £6.8 billion for EU programmes during 2022-2025, supporting the UK’s eventual association with Horizon Europe, Euratom Research and Training, and Fusion for Energy.
The extension now covers “all eligible, current applications to calls where researchers expect to sign grant agreements this year” but are unable to do so due to the ongoing delays to formalising UK association. Full details of the scope and terms of the extended guarantee are available on the UKRI website.
As usual, we encourage BU academics to apply for next Horizon Europe calls. To discuss more details about your potential HEU project, please get in touch with RDS Research Facilitator International Ainar Blaudums or your allocated Funding Development Officer.
Update on Horizon 2020 and Horizon Europe
July update on Horizon Europe
Horizon Europe – Clusters for Collaborative Research Projects










BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease